37.78 USD
-0.48 (-1.25%)
37.78 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to KEQU. KEQU was compared to 187 industry peers in the Health Care Equipment & Supplies industry. KEQU has an average financial health and profitability rating. KEQU is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
KEQU had positive earnings in the past year.
In the past year KEQU had a positive cash flow from operations.
In multiple years KEQU reported negative net income over the last 5 years.
In multiple years KEQU reported negative operating cash flow during the last 5 years.
1.2 Ratios
KEQU's Return On Assets of 6.36% is amongst the best of the industry. KEQU outperforms 85.56% of its industry peers.
KEQU's Return On Equity of 18.34% is amongst the best of the industry. KEQU outperforms 93.58% of its industry peers.
KEQU has a Return On Invested Capital of 10.92%. This is amongst the best in the industry. KEQU outperforms 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KEQU is in line with the industry average of 8.82%.
The 3 year average ROIC (9.90%) for KEQU is below the current ROIC(10.92%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROIC | 10.92% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 4.68%, KEQU is doing good in the industry, outperforming 75.94% of the companies in the same industry.
KEQU has a Operating Margin of 7.60%. This is in the better half of the industry: KEQU outperforms 74.33% of its industry peers.
Looking at the Gross Margin, with a value of 29.37%, KEQU is doing worse than 77.01% of the companies in the same industry.
KEQU's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KEQU is creating some value.
The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
KEQU has more shares outstanding than it did 5 years ago.
KEQU has a worse debt/assets ratio than last year.
2.2 Solvency
KEQU has an Altman-Z score of 3.08. This indicates that KEQU is financially healthy and has little risk of bankruptcy at the moment.
KEQU has a better Altman-Z score (3.08) than 72.19% of its industry peers.
KEQU has a debt to FCF ratio of 3.45. This is a good value and a sign of high solvency as KEQU would need 3.45 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.45, KEQU belongs to the best of the industry, outperforming 82.89% of the companies in the same industry.
KEQU has a Debt/Equity ratio of 0.91. This is a neutral value indicating KEQU is somewhat dependend on debt financing.
KEQU has a worse Debt to Equity ratio (0.91) than 73.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Altman-Z | 3.08 |
ROIC/WACC1.4
WACC7.78%
2.3 Liquidity
A Current Ratio of 2.32 indicates that KEQU has no problem at all paying its short term obligations.
The Current ratio of KEQU (2.32) is comparable to the rest of the industry.
KEQU has a Quick Ratio of 1.63. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
KEQU's Quick ratio of 1.63 is in line compared to the rest of the industry. KEQU outperforms 43.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.96%.
KEQU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.78% yearly.
The Revenue has decreased by -7.27% in the past year.
The Revenue has been growing slightly by 5.68% on average over the past years.
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%46.76%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.48, the valuation of KEQU can be described as very cheap.
96.79% of the companies in the same industry are more expensive than KEQU, based on the Price/Earnings ratio.
KEQU is valuated cheaply when we compare the Price/Earnings ratio to 26.56, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.48 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KEQU is valued cheaply inside the industry as 96.79% of the companies are valued more expensively.
98.93% of the companies in the same industry are more expensive than KEQU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.8 | ||
| EV/EBITDA | 6 |
4.3 Compensation for Growth
KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
KEQU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
37.78
-0.48 (-1.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners41.14%
Inst Owner Change1.56%
Ins Owners15.96%
Ins Owner Change0.44%
Market Cap108.43M
Revenue(TTM)146.60M
Net Income(TTM)12.30M
Analysts82.86
Price TargetN/A
Short Float %0.82%
Short Ratio1.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.48 | ||
| Fwd PE | N/A | ||
| P/S | 0.41 | ||
| P/FCF | 5.8 | ||
| P/OCF | 5.07 | ||
| P/B | 1.62 | ||
| P/tB | 2.92 | ||
| EV/EBITDA | 6 |
EPS(TTM)5.05
EY13.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.52
FCFY17.25%
OCF(TTM)7.45
OCFY19.71%
SpS91.7
BVpS23.37
TBVpS12.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number51.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROCE | 13.98% | ||
| ROIC | 10.92% | ||
| ROICexc | 12.63% | ||
| ROICexgc | 16.65% | ||
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% | ||
| FCFM | 7.11% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Debt/EBITDA | 2.38 | ||
| Cap/Depr | 48.41% | ||
| Cap/Sales | 1.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.84% | ||
| Profit Quality | 152.04% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 3.08 |
F-Score4
WACC7.78%
ROIC/WACC1.4
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%46.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y496.38%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y2996.81%
OCF growth 3YN/A
OCF growth 5Y28.86%
KEWAUNEE SCIENTIFIC CP / KEQU FAQ
What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
ChartMill assigns a fundamental rating of 4 / 10 to KEQU.
Can you provide the valuation status for KEWAUNEE SCIENTIFIC CP?
ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.
How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?
KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.
Can you provide the dividend sustainability for KEQU stock?
The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.